Quantity of KRAS mutations in cell-free DNA is associated with survival of patients with advanced cancers

被引:0
|
作者
Madwani, Kiran
Huang, Helen J.
Shelton, Dawne N.
Fu, Siqing
Tsimberidou, Apostolia M.
Piha-Paul, Sarina A.
Naing, Aung
Hong, David S.
Karp, Daniel D.
Andrews, Debra L.
Cabrilo, Goran
Kopetz, E. Scott
Luthra, Rajyalakshmi
Kee, Bryan K.
Eng, Cathy
Morris, Van K.
-Neumann, George A. Karlin
Meric-Bernstam, Funda
Janku, Filip
机构
关键词
D O I
10.1158/1538-7445.AM2016-493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
493
引用
收藏
页数:4
相关论文
共 50 条
  • [31] An Investigation into Cell-Free DNA in Different Common Cancers
    Nafar, Samira
    Hosseini, Kamran
    Shokrgozar, Negin
    Farahmandi, Amir Yousef
    Alamdari-Palangi, Vahab
    Sichani, Ali Saber
    Fallahi, Jafar
    MOLECULAR BIOTECHNOLOGY, 2023, 66 (12) : 3462 - 3474
  • [32] Detection of SPEN mutations in advanced breast cancer by circulating tumor cell-free DNA
    Dai, Charles
    Barnes, Haley
    Medford, Arielle
    Putur, Annika
    Keenan, Jennifer
    Moy, Beverly
    Wander, Seth
    Corcoran, Ryan
    Bardia, Aditya
    CANCER RESEARCH, 2024, 84 (09)
  • [33] Extraction of Cell-Free DNA Evaluation of Efficiency, Quantity, and Quality
    Terp, Simone K.
    Pedersen, Inge S.
    Stoico, Malene P.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (04): : 310 - 319
  • [34] Accurately assessing the quality and quantity of cell-free DNA extractions
    Moon, F.
    Fairley, J.
    Nahlik, K.
    Deans, S.
    VIRCHOWS ARCHIV, 2024, 485 : S429 - S429
  • [35] Cell-free DNA Tissue Sources in Patients With Advanced Lung Diseases
    Balasubramanian, S.
    Hyesik, K.
    Andargie, T. E.
    Keller, M.
    Sun, J.
    Park, W.
    Hill, T.
    Apalara, Z.
    Redekar, N.
    Jang, M. K.
    Nathan, S. D.
    Agbor, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [36] CIRCULATING CELL-FREE DNA PROFILING OF PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA
    Sonpavde, G.
    Nagy, R. J.
    Varambally, S.
    Lanman, R.
    Talasaz, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 60 : E5 - E5
  • [37] Urinary cell-free DNA as a prognostic marker for KRAS-positive advanced-stage NSCLC
    Xie, F.
    Li, P.
    Gong, J.
    Tan, H.
    Ma, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (05): : 591 - 598
  • [38] KRAS Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and KRAS G12/G13 Detection in Cell-Free DNA
    Thongyoo, Pitchasak
    Chindaprasirt, Jarin
    Aphivatanasiri, Chaiwat
    Intarawichian, Piyapharom
    Kunprom, Waritta
    Kongpetch, Sarinya
    Techasen, Anchalee
    Loilome, Watcharin
    Namwat, Nisana
    Titapun, Attapol
    Jusakul, Apinya
    CANCER GENOMICS & PROTEOMICS, 2025, 22 (01) : 112 - 126
  • [39] High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival
    Lamminaho, Maria
    Kujala, Jouni
    Peltonen, Hanna
    Tengstrom, Maria
    Kosma, Veli-Matti
    Mannermaa, Arto
    CANCERS, 2021, 13 (18)
  • [40] Novel, ultra deep next-generation sequencing of plasma cell-free DNA from patients with advanced cancers
    Janku, Filip
    Huang, Helen J.
    Ramzanali, Nishma M.
    Hong, David S.
    Karp, Daniel D.
    Cai, Xuyu
    Zhao, Yue
    Salathia, Neeraj
    Waters, Jill
    Liu, Li
    Klausner, Rick
    Meric-Bernstam, Funda
    Fan, Jian-Bing
    CANCER RESEARCH, 2015, 75